Congress quietly subsidizes supplement makers through your tax dollars
H.R. 8933 — Dietary Supplements Access Act · Filed by Darin LaHood (R-IL) · 7 cosponsors · Introduced May 20, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill allows people with Health Savings Accounts (HSAs), Archer Medical Savings Accounts (MSAs), and flexible spending arrangements to use pre-tax dollars to pay for dietary supplements—up to $500 per year ($250 if married filing separately). Currently, these accounts only cover FDA-approved medications and medical devices; dietary supplements are excluded. The bill treats supplements the same as prescription drugs for tax purposes, giving supplement purchases a tax subsidy that ordinary consumers don't get.
Why we flagged it
The bill's functional effect is to create a tax-advantaged pathway for dietary supplement purchases by reclassifying them as 'medical care' under existing health account rules. This is a targeted tax expenditure benefiting a specific industry, not a public health measure.
What the text implies
- Expands the definition of 'medical care' in tax law without requiring FDA approval or clinical evidence of efficacy—dietary supplements are not regulated as drugs and lack the same safety/efficacy standards as pharmaceuticals.
- Creates a two-tier subsidy: workers with HSAs/FSAs get a tax break on supplements; workers without these accounts (lower-income, gig workers, self-employed) do not, widening the tax-benefit gap.
The full analysis lists 4 implications of this text.
Who stands to gain
dietary supplement manufacturers; supplement retailers; natural products industry